Michael Schmitz
Dr. med.
Michael Schmitz
  • Medical specialist
  • Medical Specialist in Internal Medicine
  • Medical Specialist in Internal Medicine and Hematology and Oncology
Working area

Location

O24 , 5th Floor
Languages
German (Mother tongue)
Spanish

Areas of expertise

Publications

Zurück
  • 2020
  • 2016
  • 2015
  • 2001
Vor

Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases
Llorens F, Villar-Piqué A, Schmitz M, Diaz-Lucena D, Wohlhage M, Hermann P, Goebel S, Schmidt I, Glatzel M, Hauw J, Sikorska B, Liberski P, Riggert J, Ferrer I, Zerr I
NEUROPATH APPL NEURO. 2020;46(3):240-254.

Severe and irreversible myelopathy after concurrent systemic and intrathecal nucleoside analogue treatment for refractory diffuse large B-cell lymphoma: A case report and review of the literature
Alsdorf W, Schmitz M, Schieferdecker A, Dierlamm J, Bokemeyer C, Binder M
J ONCOL PHARM PRACT. 2016;22(3):523-7.

Integration von palliativmedizinischer Betreuung – Ist früher besser?
Schmitz M, Bokemeyer C, Oechsle K
ONKOLOGE. 2015;21(1):848-851.

Needs, symptoms, and outcome of patients with advanced head and neck cancer treated on a palliative care inpatient ward
Schmitz M, Wolfram M, Bokemeyer C, Oechsle K
2015. Gemeinsame Jahrestagung, Basel, Oktober 2015: Abstracts. .

Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma
Thiede C, Wündisch T, Alpen B, Neubauer B, Morgner A, Schmitz M, Ehninger G, Stolte M, Bayerdörffer E, Neubauer A
J CLIN ONCOL. 2001;19(6):1600-9.

Letzte Aktualisierung aus dem FIS: 25.04.2024 - 05:09 Uhr